Transcription factors and muscle differentiation

Cell Cycle Regulation and Differentiation in Cardiovascular and Neural Systems

Volumn , Issue , 2010, Pages 35-68

  Cabello, Gérard ^a   Casas, François ^a   Wrutniak Cabello, Chantal ^a  

^a UNIV MONTPELLIER   (France)

Author keywords

BHLH transcription factors; Cellular oncogenes; Myoblast differentiation; Retinoic acid receptors; T3 mitochondrial receptors; Triiodothyronine (T3) nuclear receptor

Indexed keywords

EID: 84865439205     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-60327-153-0_3     Document Type: Chapter

References (196)

1. Buckingham M, Bajard L, Chang T, et al (2003) The formation of skeletal muscle: From somite to limb. J Anat 202(1):59-68
2. Braun T, Buschhausen-Denker G, Bober E, Tannich E, Arnold HH (1989) A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts. Embo J 8(3):701-709
3. Choi J, Costa ML, Mermelstein CS, Chagas C, Holtzer S, Holtzer H (1990) MyoD converts primary dermal fibroblasts, chondroblasts, smooth muscle, and retinal pigmented epithelial cells into striated mononucleated myoblasts and multinucleated myotubes. Proc Natl Acad Sci U S A 87(20):7988-7992
4. Rhodes SJ, Konieczny SF (1989) Identification of MRF4: A new member of the muscle regulatory factor gene family. Genes Dev 3(12B):2050-2061
5. Tapscott SJ, Davis RL, Thayer MJ, Cheng PF, Weintraub H, Lassar AB (1988) MyoD1: A nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. Science 242(4877):405-411
6. Wright WE, Sassoon DA, Lin VK (1989) Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell 56(4):607-617
7. RudnickiMA, Schnegelsberg PN, Stead RH, Braun T, Arnold HH, Jaenisch R (1993) MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 75(7):1351-1359
8. Hasty P, Bradley A, Morris JH, et al (1993) Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature 364(6437):501-506
9. Nabeshima Y, Hanaoka K, Hayasaka M, et al (1993) Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature 364(6437):532-535
10. Bober E, Lyons GE, Braun T, Cossu G, Buckingham M, Arnold HH (1991) The muscle regulatory gene, Myf-6, has a biphasic pattern of expression during early mouse development. J Cell Biol 113(6):1255-1265
11. Kassar-Duchossoy L, Gayraud-Morel B, Gomes D, et al (2004) Mrf4 determines skeletal muscle identity in Myf5:Myod double-mutant mice. Nature 431(7007):466-471
12. Kouzarides T (1995) Transcriptional control by the retinoblastoma protein. Semin Cancer Biol 6(2):91-98
13. Taya Y (1997) RB kinases and RB-binding proteins: New points of view. Trends Biochem Sci 22(1):14-17
14. Mittnacht S (1998) Control of pRB phosphorylation. Curr Opin Genet Dev 8(1):21-27
15. Gu W, Schneider JW, Condorelli G, Kaushal S, Mahdavi V, Nadal-Ginard B (1993) Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72(3):309-324
16. Zhang JM, Wei Q, Zhao X, Paterson BM (1999) Coupling of the cell cycle and myogenesis through the cyclin D1-dependent interaction of MyoD with cdk4. Embo J 18(4):926-933
17. Rao SS, Chu C, Kohtz DS (1994) Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators. Mol Cell Biol 14(8): 5259-5267
18. Skapek SX, Rhee J, Spicer DB, Lassar AB (1995) Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 267(5200):1022-1024
19. Lassar AB, Davis RL, Wright WE, et al (1991) Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell 66(2): 305-315
20. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H (1990) The protein Id: A negative regulator of helix-loop-helix DNA binding proteins. Cell 61(1):49-59
21. Lemercier C, To RQ, Carrasco RA, Konieczny SF (1998) The basic helix-loop-helix transcription factor Mist1 functions as a transcriptional repressor of myoD. Embo J 17(5):1412-1422
22. Lu J,Webb R, Richardson JA, Olson EN (1999) MyoR: A muscle-restricted basic helix-loophelix transcription factor that antagonizes the actions of MyoD. Proc Natl Acad Sci U S A 96(2):552-557
23. Hebrok M,Wertz K, Fuchtbauer EM(1994) M-Twist is an inhibitor of muscle differentiation. Dev Biol 165(2):537-544
24. Postigo AA, Dean DC (1997) ZEB, a vertebrate homolog of Drosophila Zfh-1, is a negative regulator of muscle differentiation. Embo J 16(13):3935-3943
25. Miner JH, Wold BJ (1991) c-myc inhibition of MyoD and myogenin-initiated myogenic differentiation. Mol Cell Biol 11(5):2842-2851
26. Seyer P, Grandemange S, Busson M, et al (2006) Mitochondrial activity regulates myoblast differentiation by control of c-Myc expression. J Cell Physiol 207(1):75-86
27. Rochard P, Rodier A, Casas F et al (2000) Mitochondrial activity is involved in the regulation of myoblast differentiation through myogenin expression and activity of myogenic factors. J Biol Chem 275(4):2733-2744
28. Sartorelli V, Huang J, Hamamori Y, Kedes L (1997) Molecular mechanisms of myogenic coactivation by p300: Direct interaction with the activation domain of MyoD and with the MADS box of MEF2C. Mol Cell Biol 17(2):1010-1026
29. Yuan W, Condorelli G, Caruso M, Felsani A, Giordano A (1996) Human p300 protein is a coactivator for the transcription factor MyoD. J Biol Chem 271(15):9009-9013
30. Puri PL, Sartorelli V, Yang XJ et al (1997) Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. Mol Cell 1(1):35-45
31. Sartorelli V, Puri PL, Hamamori Y et al (1999) Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program. Mol Cell 4(5):725-734
32. Busson M, Carazo A, Seyer P, et al (2005) Coactivation of nuclear receptors and myogenic factors induces the major BTG1 influence on muscle differentiation. Oncogene 24(10):1698-1710
33. Marchal S, Cassar-Malek I, Magaud JP, Rouault JP, Wrutniak C, Cabello G (1995) Stimulation of avian myoblast differentiation by triiodothyronine: Possible involvement of the cAMP pathway. Exp Cell Res 220(1):1-10
34. Rodier A, Marchal-Victorion S, Rochard P et al (1999) BTG1: A triiodothyronine target involved in the myogenic influence of the hormone. Exp Cell Res 249(2):337-348
35. Angel P, Allegretto EA, Okino ST et al (1988) Oncogene jun encodes a sequence-specific trans-Activator similar to AP-1. Nature 332(6160):166-171
36. Angel P, Imagawa M, Chiu R, et al (1987) Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-Acting factor. Cell 49(6):729-739
37. Curran T, Franza BR Jr (1988) Fos and Jun: The AP-1 connection. Cell 55(3):395-397
38. Halazonetis TD, Georgopoulos K, Greenberg ME, Leder P (1988) c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities. Cell 55(5):917-924
39. Hirai S, Yaniv M (1989) Jun DNA-binding is modulated by mutations between the leucines or by direct interaction of fos with the TGACTCA sequence. New Biol 1(2):181-191
40. Sassone-Corsi P, Lamph WW, Kamps M, Verma IM (1988) fos-Associated cellular p39 is related to nuclear transcription factor AP-1. Cell 54(4):553-560
41. Hai T, Curran T (1991) Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc Natl Acad Sci U S A 88(9):3720-3724
42. Kataoka K, Noda M, Nishizawa M (1994) Maf nuclear oncoprotein recognizes sequences related to an AP-1 site and forms heterodimers with both Fos and Jun. Mol Cell Biol 14(1):700-712
43. Kerppola TK, Curran T (1994) Maf and Nrl can bind to AP-1 sites and form heterodimers with Fos and Jun. Oncogene 9(3):675-684
44. Kouzarides T, Ziff E (1988) The role of the leucine zipper in the fos-jun interaction. Nature 336(6200):646-651
45. Landschulz WH, Johnson PF, McKnight SL (1988) The leucine zipper: A hypothetical structure common to a new class of DNA binding proteins. Science 240(4860):1759-1764
46. Mechta-Grigoriou F, Gerald D, Yaniv M (2001) The mammalian Jun proteins: Redundancy and specificity. Oncogene 20(19):2378-2389
47. van Dam H, Duyndam M, Rottier R et al (1993) Heterodimer formation of cJun and ATF-2 is responsible for induction of c-jun by the 243 amino acid adenovirus E1A protein. Embo J 12(2):479-487
48. Hagmeyer BM, Konig H, Herr I et al (1993) Adenovirus E1A negatively and positively modulates transcription of AP-1 dependent genes by dimer-specific regulation of the DNA binding and transactivation activities of Jun. Embo J 12(9):3559-3572
49. Stein B, Angel P, van Dam H, et al (1992) Ultraviolet-radiation induced c-jun gene transcription: Two AP-1 like binding sites mediate the response. Photochem Photobiol 55(3):409-415
50. Shin HM, Han TH (1999) CD28-mediated regulation of the c-jun promoter involves the MEF2 transcription factor in Jurkat T cells. Mol Immunol 36(3):197-203
51. Andreucci JJ, Grant D, Cox DM et al (2002) Composition and function of AP-1 transcription complexes during muscle cell differentiation. J Biol Chem 277(19):16426-16432
52. Chen RH, Abate C, Blenis J (1993) Phosphorylation of the c-Fos transrepression domain by mitogen-Activated protein kinase and 90-kDa ribosomal S6 kinase. Proc Natl Acad Sci U S A 90(23):10952-10956
53. Deng T, KarinM (1994) c-Fos transcriptional activity stimulated by H-Ras-Activated protein kinase distinct from JNK and ERK. Nature 371(6493):171-175
54. Raingeaud J, Gupta S, Rogers JS et al (1995) Pro-inflammatory cytokines and environmental stress cause p38 mitogen-Activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 270(13):7420-7426
55. Papavassiliou AG, TreierM, Bohmann D (1995) Intramolecular signal transduction in c-Jun. Embo J 14(9):2014-2019
56. Arias J, Alberts AS, Brindle P et al (1994) Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature 370(6486):226-229
57. Bannister AJ, Oehler T, Wilhelm D, Angel P, Kouzarides T (1995) Stimulation of c-Jun activity by CBP: C-Jun residues Ser63/73 are required for CBP induced stimulation in vivo and CBP binding in vitro. Oncogene 11(12):2509-2514
58. Musti AM, TreierM, Bohmann D (1997) Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases. Science 275(5298):400-402
59. Kovary K, Bravo R (1991) The jun and fos protein families are both required for cell cycle progression in fibroblasts. Mol Cell Biol 11(9):4466-4472
60. Riabowol K, Schiff J, Gilman MZ (1992) Transcription factor AP-1 activity is required for initiation of DNA synthesis and is lost during cellular aging. Proc Natl Acad Sci U S A 89(1):157-161
61. Pfarr CM, Mechta F, Spyrou G, Lallemand D, Carillo S, Yaniv M (1994) Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras. Cell 76(4): 747-760
62. Bakiri L, Lallemand D, Bossy-Wetzel E, Yaniv M (2000) Cell cycle-dependent variations in c-Jun and JunB phosphorylation: A role in the control of cyclin D1 expression. Embo J 19(9):2056-2068
63. Johnson RS, van Lingen B, Papaioannou VE, Spiegelman BM (1993) A null mutation at the c-jun locus causes embryonic lethality and retarded cell growth in culture. Genes Dev 7(7B):1309-1317
64. Schreiber M, Kolbus A, Piu F et al (1999) Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev 13(5):607-619
65. Lord KA, Abdollahi A, Hoffman-Liebermann B, Liebermann DA (1993) Proto-oncogenes of the fos/jun family of transcription factors are positive regulators of myeloid differentiation. Mol Cell Biol 13(2):841-851
66. Szabo E, Preis LH, Birrer MJ (1994) Constitutive cJun expression induces partial macrophage differentiation in U-937 cells. Cell Growth Differ 5(4):439-446
67. Sark MW, Fischer DF, de Meijer E, van de Putte P, Backendorf C (1998) AP-1 and ets transcription factors regulate the expression of the human SPRR1A keratinocyte terminal differentiation marker. J Biol Chem 273(38):24683-24692
68. Navre M, Ringold GM (1988) A growth factor-repressible gene associated with protein kinase C-mediated inhibition of adipocyte differentiation. J Cell Biol 107(1):279-286
69. Kameda T,Watanabe H, Iba H (1997) C-Jun and JunD suppress maturation of chondrocytes. Cell Growth Differ 8(5):495-503
70. Park K, Chung M, Kim SJ (1992) Inhibition of myogenesis by okadaic acid, an inhibitor of protein phosphatases, 1 and 2A, correlates with the induction of AP1. J Biol Chem 267(15):10810-10815
71. Sulakhe PV, Johnson DD, Phan NT, Wilcox R (1985) Phorbol ester inhibits myoblast fusion and activates beta-Adrenergic receptor coupled adenylate cyclase. FEBS Lett 186(2): 281-285
72. Daury L, Busson M, Tourkine N et al (2001) Opposing functions of ATF2 and Fos-like transcription factors in c-Jun-mediated myogenin expression and terminal differentiation of avian myoblasts. Oncogene 20(55):7998-8008
73. Pedraza-Alva G, Zingg JM, Jost JP (1994) AP-1 binds to a putative cAMP response element of the MyoD1 promoter and negatively modulates MyoD1 expression in dividing myoblasts. J Biol Chem 269(9):6978-6985
74. Du R, Chen YF, An XR et al (2005) Cloning and sequence analysis of myostatin promoter in sheep. DNA Seq 16(6):412-417
75. Joulia D, Bernardi H, Garandel V, Rabenoelina F, Vernus B, Cabello G (2003) Mechanisms involved in the inhibition of myoblast proliferation and differentiation by myostatin. Exp Cell Res 286(2):263-275
76. Bengal E, Ransone L, Scharfmann R et al (1992) Functional antagonism between c-Jun and MyoD proteins: A direct physical association. Cell 68(3):507-519
77. Thinakaran G, Bag J (1993) Expression of the protooncogene c-jun is maintained during myogenic differentiation in rat L6 myoblasts. Biochem Cell Biol 71(5-6):260-269
78. Serria MS, Ikeda H, Omoteyama K, Hirokawa J, Nishi S, Sakai M (2003) Regulation and differential expression of the c-maf gene in differentiating cultured cells. Biochem Biophys Res Commun 310(2):318-326
79. Raingeaud J, Whitmarsh AJ, Barrett T, Derijard B, Davis RJ (1996) MKK3-And MKK6-regulated gene expression is mediated by the p38 mitogen-Activated protein kinase signal transduction pathway. Mol Cell Biol 16(3):1247-1255
80. van Dam H, Wilhelm D, Herr I, Steffen A, Herrlich P, Angel P (1995) ATF-2 is preferentially activated by stress-Activated protein kinases to mediate c-jun induction in response to genotoxic agents. Embo J 14(8):1798-1811
81. Cuenda A, Cohen P (1999) Stress-Activated protein kinase-2/p38 and a rapamycin-sensitive pathway are required for C2C12 myogenesis. J Biol Chem 274(7):4341-4346
82. Wu Z, Woodring PJ, Bhakta KS et al (2000) p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps. Mol Cell Biol 20(11):3951-3964
83. Zetser A, Gredinger E, Bengal E (1999) p38 mitogen-Activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2c transcription factor. J Biol Chem 274(8):5193-5200
84. Dorman CM, Johnson SE (1999) Activated Raf inhibits avian myogenesis through aMAPKdependent mechanism. Oncogene 18(37):5167-5176
85. Nesbit CE, Tersak JM, Prochownik EV (1999) MYC oncogenes and human neoplastic disease. Oncogene 18(19):3004-3016
86. Coller HA, Grandori C, Tamayo P et al (2000) Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. Proc Natl Acad Sci U S A 97(7):3260-3265
87. Grignani F, Lombardi L, Inghirami G, Sternas L, Cechova K, Dalla-Favera R (1990) Negative autoregulation of c-myc gene expression is inactivated in transformed cells. Embo J 9(12):3913-3922
88. Penn LJ, Brooks MW, Laufer EM, Land H (1990) Negative autoregulation of c-myc transcription. Embo J 9(4):1113-1121
89. Xiao Q, Claassen G, Shi J, Adachi S, Sedivy J, Hann SR (1998) Transactivation-defective c-MycS retains the ability to regulate proliferation and apoptosis. Genes Dev 12(24): 3803-3808
90. Claassen GF, Hann SR (1999) Myc-mediated transformation: The repression connection. Oncogene 18(19):2925-2933
91. Amati B, Frank SR, Donjerkovic D, Taubert S (2001) Function of the c-Myc oncoprotein in chromatin remodeling and transcription. Biochim Biophys Acta 1471(3):M135-145
92. Furstoss O, Dorey K, Simon V, Barila D, Superti-Furga G, Roche S (2002) c-Abl is an effector of Src for growth factor-induced c-myc expression and DNA synthesis. Embo J 21(4):514-524
93. Grausz JD, Fradelizi D, Dautry F, Monier R, Lehn P (1986) Modulation of c-fos and c-myc mRNA levels in normal human lymphocytes by calcium ionophore A23187 and phorbol ester. Eur J Immunol 16(10):1217-1221
94. Kim DW, Gazourian L, Quadri SA, Romieu-Mourez R, Sherr DH, Sonenshein GE (2000) The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells. Oncogene 19(48):5498-5506
95. Maki A, Berezesky IK, Fargnoli J, Holbrook NJ, Trump BF (1992) Role of [Ca2+]i in induction of c-fos, c-jun, and c-myc mRNA in rat PTE after oxidative stress. Faseb J 6(3):919-924
96. Reuse S, Maenhaut C, Dumont JE (1990) Regulation of protooncogenes c-fos and c-myc expressions by protein tyrosine kinase, protein kinase C, and cyclic AMP mitogenic pathways in dog primary thyrocytes: A positive and negative control by cyclic AMP on c-myc expression. Exp Cell Res 189(1):33-40
97. Slungaard A, Confer DL, Schubach WH (1987) Rapid transcriptional down-regulation of c-myc expression during cyclic adenosine monophosphate- promoted differentiation of leukemic cells. J Clin Invest 79(5):1542-1547
98. Paulin FE, West MJ, Sullivan NF, Whitney RL, Lyne L, Willis AE (1996) Aberrant translational control of the c-myc gene in multiple myeloma. Oncogene 13(3):505-513
99. West MJ, Sullivan NF, Willis AE (1995) Translational upregulation of the c-myc oncogene in Bloom's syndrome cell lines. Oncogene 11(12):2515-2524
100. Gregory MA, Hann SR (2000) c-Myc proteolysis by the ubiquitin-proteasome pathway: Stabilization of c-Myc in Burkitt's lymphoma cells. Mol Cell Biol 20(7):2423-2435
101. Salghetti SE, Kim SY, Tansey WP (1999) Destruction of Myc by ubiquitin-mediated proteolysis: Cancer-Associated and transforming mutations stabilize Myc. Embo J 18(3):717-726
102. Herbst A, Salghetti SE, Kim SY, Tansey WP (2004) Multiple cell-Type-specific elements regulate Myc protein stability. Oncogene 23(21):3863-3871
103. Antonson P, Pray MG, Jacobsson A, Xanthopoulos KG (1995) Myc inhibits CCAAT/enhancer-binding protein alpha-gene expression in HIB-1B hibernoma cells through interactions with the core promoter region. Eur J Biochem 232(2):397-403
104. Li LH, Nerlov C, Prendergast G, MacGregor D, Ziff EB (1994) c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. Embo J 13(17):4070-4079
105. Berns K, Martins C, Dannenberg JH, Berns A, te Riele H, Bernards R (2000) p27kip1-independent cell cycle regulation by MYC. Oncogene 19(42):4822-4827
106. Claassen GF, Hann SR (2000) A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest. Proc Natl Acad Sci U S A 97(17):9498-9503
107. Wu S, Cetinkaya C, Munoz-Alonso MJ, et al (2003) Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter. Oncogene 22(3):351-360
108. Yang W, Shen J, Wu M et al (2001) Repression of transcription of the p27(Kip1) cyclindependent kinase inhibitor gene by c-Myc. Oncogene 20(14):1688-1702
109. Denis N, Blanc S, Leibovitch MP et al (1987) c-myc oncogene expression inhibits the initiation of myogenic differentiation. Exp Cell Res 172(1):212-217
110. Sejersen T, Sumegi J, Ringertz NR (1985) Density-dependent arrest of DNA replication is accompanied by decreased levels of c-myc mRNA in myogenic but not in differentiationdefective myoblasts. J Cell Physiol 125(3):465-470
111. Yeilding NM, Procopio WN, Rehman MT, Lee WM (1998) c-myc mRNA is downregulated during myogenic differentiation by accelerated decay that depends on translation of regulatory coding elements. J Biol Chem 273(25):15749-15757
112. Crescenzi M, Crouch DH, Tato F (1994) Transformation by myc prevents fusion but not biochemical differentiation of C2C12 myoblasts: Mechanisms of phenotypic correction in mixed culture with normal cells. J Cell Biol 125(5):1137-1145
113. Martinez-Fernandez S, Hernandez-Torres F, Franco D, Lyons GE, Navarro F, Aranega AE (2006) Pitx2c overexpression promotes cell proliferation and arrests differentiation in myoblasts. Dev Dyn 235(11):2930-2939
114. Kataoka Y, Matsumura I, Ezoe S et al (2003) Reciprocal inhibition between MyoD and STAT3 in the regulation of growth and differentiation of myoblasts. J Biol Chem 278(45):44178-44187
115. Zentella A, Massague J (1992) Transforming growth factor beta induces myoblast differentiation in the presence of mitogens. Proc Natl Acad Sci U S A 89(11):5176-5180
116. Datta B, Min W, Burma S, Lengyel P (1998) Increase in p202 expression during skeletal muscle differentiation: Inhibition of MyoD protein expression and activity by p202. Mol Cell Biol 18(2):1074-1083
117. Wang H, Liu C, Lu Y et al (2000) The interferon-And differentiation- inducible p202a protein inhibits the transcriptional activity of c-Myc by blocking its association with Max. J Biol Chem 275(35):27377-27285
118. Kronfeld-Kinar Y, Vilchik S, Hyman T, Leibkowicz F, Salzberg S (1999) Involvement of PKR in the regulation of myogenesis. Cell Growth Differ 10(3):201-212
119. Galaktionov K, Chen X, Beach D (1996) Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 382(6591):511-517
120. Prochownik EV, Kukowska J, Rodgers C (1988) c-myc antisense transcripts accelerate differentiation and inhibit G1 progression in murine erythroleukemia cells. Mol Cell Biol 8(9):3683-3695
121. Steiner P, Philipp A, Lukas J et al (1995) Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes. Embo J 14(19):4814-4826
122. Steinman RA, Hoffman B, Iro A, Guillouf C, Liebermann DA, el-Houseini ME (1994) Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 9(11):3389-3396
123. Kitaura H, Shinshi M, Uchikoshi Y, Ono T, Iguchi-Ariga SM, Ariga H (2000) Reciprocal regulation via protein-protein interaction between c-Myc and p21(cip1/waf1/sdi1) in DNA replication and transcription. J Biol Chem 275(14):10477-10483
124. Lasorella A, Noseda M, Beyna M, Yokota Y, Iavarone A (2000) Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins. Nature 407(6804): 592-598
125. La Rocca SA, Crouch DH, Gillespie DA (1994). c-Myc inhibits myogenic differentiation and myoD expression by a mechanism which can be dissociated from cell transformation. Oncogene 9(12):3499-3508
126. La Rocca SA, Vannucchi S, Pompili M et al (2002). Selective repression of myoD transcription by v-Myc prevents terminal differentiation of quail embryo myoblasts transformed by the MC29 strain of avian myelocytomatosis virus. Oncogene 21(31):4838-4842
127. Beato M, Herrlich P, Schutz G (1995). Steroid hormone receptors: Many actors in search of a plot. Cell 83(6):851-857
128. Yen PM (2001). Physiological and molecular basis of thyroid hormone action. Physiol Rev 81(3):1097-1142
129. Chin S, Apriletti J, Gick G (1998) Characterization of a negative thyroid hormone response element in the rat sodium, potassium-Adenosine triphosphatase alpha3 gene promoter. Endocrinology 139(8):3423-3431
130. Taylor AH, Wishart P, Lawless DE, Raymond J, Wong NC (1996) Identification of functional positive and negative thyroid hormone-responsive elements in the rat apolipoprotein AI promoter. Biochemistry 35(25):8281-8288
131. Wight PA, Crew MD, Spindler SR (1987) Discrete positive and negative thyroid hormoneresponsive transcription regulatory elements of the rat growth hormone gene. J Biol Chem 262(12):5659-5663
132. Drabkin H, Kao FT, Hartz J et al (1988) Localization of human ERBA2 to the 3p22-3p24.1 region of chromosome 3 and variable deletion in small cell lung cancer. Proc Natl Acad Sci U S A 85(23):9258-9262
133. Thompson CC, Evans RM (1989) Trans-Activation by thyroid hormone receptors: Functional parallels with steroid hormone receptors. Proc Natl Acad Sci U S A 86(10):3494-3498
134. Flamant F, Samarut J (2003) Thyroid hormone receptors: Lessons from knockout and knockin mutant mice. Trends Endocrinol Metab 14(2):85-90
135. Schrader M, Muller KM, Nayeri S, Kahlen JP, Carlberg C (1994) Vitamin D3-Thyroid hormone receptor heterodimer polarity directs ligand sensitivity of transactivation. Nature 370(6488):382-386
136. Bogazzi F, Hudson LD, Nikodem VM (1994) A novel heterodimerization partner for thyroid hormone receptor. Peroxisome proliferator-Activated receptor. J Biol Chem 269(16): 11683-11686
137. Forman BM, Yang CR, Au M, Casanova J, Ghysdael J, Samuels HH (1989) A domain containing leucine-zipper-like motifs mediate novel in vivo interactions between the thyroid hormone and retinoic acid receptors. Mol Endocrinol 3(10):1610-1626
138. Glass CK, Lipkin SM, Devary OV, Rosenfeld MG (1989) Positive and negative regulation of gene transcription by a retinoic acid-Thyroid hormone receptor heterodimer. Cell 59(4): 697-708
139. Sugawara A, Yen PM, Darling DS, ChinWW(1993) Characterization and tissue expression of multiple triiodothyronine receptor-Auxiliary proteins and their relationship to the retinoid X-receptors. Endocrinology 133(3):965-971
140. Desbois C, Aubert D, Legrand C, Pain B, Samarut J (1991) A novel mechanism of action for v-ErbA: Abrogation of the inactivation of transcription factor AP-1 by retinoic acid and thyroid hormone receptors. Cell 67(4):731-740
141. Zhang XK, Wills KN, Husmann M, Hermann T, Pfahl M (1991) Novel pathway for thyroid hormone receptor action through interaction with jun and fos oncogene activities. Mol Cell Biol 11(12):6016-6025
142. Marchal S, Cassar-Malek I, Pons F, Wrutniak C, Cabello G (1993) Triiodothyronine influences quail myoblast proliferation and differentiation. Biol Cell 78(3):191-197
143. Cassar-Malek I, Marchal S, Rochard P, et al (1996) Induction of c-Erb A-AP-1 interactions and c-Erb A transcriptional activity in myoblasts by RXR. Consequences for muscle differentiation. J Biol Chem 271(19):11392-11399
144. Downes M, Griggs R, Atkins A, Olson EN, Muscat GE (1993) Identification of a thyroid hormone response element in the mouse myogenin gene: Characterization of the thyroid hormone and retinoid X receptor heterodimeric binding site. Cell Growth Differ 4(11): 901-909
145. Leblond-Larouche L, Morais R, Zollinger M (1979) Studies of the effect of chloramphenicol, ethidium bromide and camptothecin on the reproduction of Rous sarcoma virus in infected chick embryo cells. J Gen Virol 44(2):323-331
146. Morais R, Gregoire M, Jeannotte L, Gravel D (1980) Chick embryo cells rendered respiration-deficient by chloramphenicol and ethidium bromide are auxotrophic for pyrimidines. Biochem Biophys Res Commun 94(1):71-77
147. van den Bogert C, Spelbrink JN, Dekker HL (1992) Relationship between culture conditions and the dependency on mitochondrial function of mammalian cell proliferation. J Cell Physiol 152(3):632-638
148. Hamai N, Nakamura M, Asano A (1997) Inhibition of mitochondrial protein synthesis impaired C2C12 myoblast differentiation. Cell Struct Funct 22(4):421-431
149. Kaneko T, Watanabe T, Oishi M (1988) Effect of mitochondrial protein synthesis inhibitors on erythroid differentiation of mouse erythroleukemia (Friend) cells. Mol Cell Biol 8(8):3311-3315
150. Korohoda W, Pietrzkowski Z, Reiss K (1993) Chloramphenicol, an inhibitor of mitochondrial protein synthesis, inhibits myoblast fusion and myotube differentiation. Folia Histochem Cytobiol 31(1):9-13
151. Vayssiere JL, Cordeau-Lossouarn L, Larcher JC, Basseville M, Gros F, Croizat B (1992) Participation of the mitochondrial genome in the differentiation of neuroblastoma cells. In Vitro Cell Dev Biol 28A(11-12):763-772
152. Newmeyer DD, Ferguson-Miller S (2003) Mitochondria: Releasing power for life and unleashing the machineries of death. Cell 112(4):481-490
153. Larsson NG, Wang J, Wilhelmsson H et al (1998) Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nat Genet 18(3):231-236
154. Wallace DC (2000) Mitochondrial defects in cardiomyopathy and neuromuscular disease. Am Heart J 139(2 Pt 3):S70-85
155. Rochard P, Cassar-Malek I,Marchal S, Wrutniak C, Cabello G (1996) Changes in mitochondrial activity during avian myoblast differentiation: Influence of triiodothyronine or v-erb A expression. J Cell Physiol 168(2):239-247
156. Shadel GS, Clayton DA (1997) Mitochondrial DNA maintenance in vertebrates. Annu Rev Biochem 66:409-435
157. Falkenberg M, Gaspari M, Rantanen A, Trifunovic A, Larsson NG, Gustafsson CM (2002) Mitochondrial transcription factors B1 and B2 activate transcription of human mtDNA. Nat Genet 31(3):289-294
158. McCulloch V, Seidel-Rogol BL, Shadel GS (2002) A human mitochondrial transcription factor is related to RNA adenine methyltransferases and binds S-Adenosylmethionine. Mol Cell Biol 22(4):1116-1125
159. Wrutniak C, Cassar-Malek I, Marchal S et al (1995) A 43-kDa protein related to c-Erb A [IMAGE]1 is located in the mitochondrial matrix of rat liver. J Biol Chem 270(27): 16347-16354
160. Casas F, Domenjoud L, Rochard P et al (2000) A 45 kDa protein related to PPARgamma2, induced by peroxisome proliferators, is located in the mitochondrial matrix. FEBS Lett 478(1-2):4-8
161. Wrutniak C, Rochard P, Casas F, Fraysse A, Charrier J, Cabello G (1998) Physiological importance of the T3 mitochondrial pathway. Ann NY Acad Sci 839:93-100
162. Casas F, Rochard P, Rodier A et al (1999) A variant form of the nuclear triiodothyronine receptor c-ErbAalpha1 plays a direct role in regulation of mitochondrial RNA synthesis. Mol Cell Biol 19(12):7913-7924
163. Casas F, Daury L, Grandemange S et al (2003) Endocrine regulation of mitochondrial activity: Involvement of truncated RXRalpha and c-Erb Aalpha1 proteins. Faseb J 17(3):426-436
164. Seyer P, Grandemange S, Pessemesse L et al (2006) L'activité mitochondriale est un régulateur majeur de la différenciation des myoblastes et de l'expression des isoformes de myosine. Prod Anim 19:279-286
165. Casas F, Pessemesse L, Grandemange S et al (2008) Overexpression of the T3 mitochondrial receptor in mice induces changes in metabolic and contractile features of muscle fibers. PLoS One 3:e2501
166. Downes M, Mynett-Johnson L, Muscat GE (1994) The retinoic acid and retinoid X receptors are differentially expressed during myoblast differentiation. Endocrinology 134(6): 2658-2661
167. Busson M, Daury L, Seyer P et al (2006) Avian MyoD and c-Jun coordinately induce transcriptional activity of the 3,5,3'-Triiodothyronine nuclear receptor c-ErbAalpha1 in proliferating myoblasts. Endocrinology 147(7):3408-3418
168. Baris O, Seyer P, Busson M et al (2007) Identification of mitochondrial activity target genes during myoblast differentiation. FEBS Advanced Lecture Series -Mitochondria in Life, Death and Disease, AUSSOIS (France), 14-16
169. Daury L, Busson M, Casas F, Cassar-Malek I, Wrutniak-Cabello C, Cabello G (2001) The triiodothyronine nuclear receptor c-ErbAalpha1 inhibits avian MyoD transcriptional activity in myoblasts. FEBS Lett 508(2):236-240
170. Casas F, BussonM, Grandemange S et al (2006) Characterization of a novel thyroid hormone receptor alpha variant involved in the regulation of myoblast differentiation. Mol Endocrinol 20(4):749-763
171. Claret FX, Antakly T, Karin M, Saatcioglu F (1996) A shift in the ligand responsiveness of thyroid hormone receptor alpha induced by heterodimerization with retinoid X receptor alpha. Mol Cell Biol 16(1):219-227
172. Flamant F, Samarut J (1998) Involvement of thyroid hormone and its alpha receptor in avian neurulation. Dev Biol 197(1):1-11
173. Li L, Chambard JC, Karin M, Olson EN (1992) Fos and Jun repress transcriptional activation by myogenin and MyoD: The amino terminus of Jun can mediate repression. Genes Dev 6(4):676-689
174. Rimokh R, Rouault JP, Wahbi K et al (1991) A chromosome 12 coding region is juxtaposed to the MYC protooncogene locus in a t(812)(q24q22) translocation in a case of B-cell chronic lymphocytic leukemia. Genes Chromosomes Cancer 3(1):24-36
175. Matsuda S, Rouault J, Magaud J, Berthet C (2001) In search of a function for the TIS21/PC3/BTG1/TOB family. FEBS Lett 497(2-3):67-72
176. Rouault JP, Rimokh R, Tessa C et al (1992) BTG1, a member of a new family of antiproliferative genes. Embo J 11(4):1663-1670
177. Westernacher D, Schaper W (1995) A novel heart derived inhibitor of vascular cell proliferation. Purification and biological activity. J Mol Cell Cardiol 27(8):1535-1543
178. Rodier A, Rochard P, Berthet C et al (2001) Identification of functional domains involved in BTG1 cell localization. Oncogene 20(21):2691-2703
179. Grandemange S, Seyer P, Carazo A et al (2005) Stimulation of mitochondrial activity by p43 overexpression induces human dermal fibroblast transformation. Cancer Res 65(10): 4282-4291
180. Delling U, Tureckova J, Lim HW, De Windt LJ, Rotwein P, Molkentin JD (2000) A calcineurin-NFATc3-dependent pathway regulates skeletal muscle differentiation and slow myosin heavy-chain expression. Mol Cell Biol 20(17):6600-6611
181. Friday BB, Horsley V, Pavlath GK (2000) Calcineurin activity is required for the initiation of skeletal muscle differentiation. J Cell Biol 149(3):657-666
182. Xu Q, Yu L, Liu L et al (2002) p38 Mitogen-Activated protein kinase-, calcium-calmodulindependent protein kinase-, and calcineurin-mediated signaling pathways transcriptionally regulate myogenin expression. Mol Biol Cell 13(6):1940-1952
183. Chin ER, Olson EN, Richardson JA et al (1998) A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev 12(16):2499-2509
184. Meissner JD, Umeda PK, Chang KC, Gros G, Scheibe RJ (2007) Activation of the beta myosin heavy chain promoter by MEF-2D, MyoD, p300, and the calcineurin/NFATc1 pathway. J Cell Physiol 211(1):138-148
185. Trenker M, Malli R, Fertschai I, Levak-Frank S, Graier WF (2007) Uncoupling proteins 2 and 3 are fundamental for mitochondrial Ca2+ uniport. Nat Cell Biol 9(4):445-452
186. Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu SS (2004) Calcium, ATP, and ROS: A mitochondrial love-hate triangle. Am J Physiol Cell Physiol 287(4):C817-833
187. Rizzuto R, Pinton P, Carrington W et al (1998) Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca2+ responses. Science 280(5370): 1763-1766
188. Reed JC, Nowell PC, Hoover RG (1985) Regulation of c-myc mRNA levels in normal human lymphocytes by modulators of cell proliferation. Proc Natl Acad Sci U S A 82(12): 4221-4224
189. Tsuda T, Kaibuchi K, West B, Takai Y (1985) Involvement of Ca2+ in platelet-derived growth factor-induced expression of c-myc oncogene in Swiss 3T3 fibroblasts. FEBS Lett 187(1):43-46
190. Bubici C, Papa S, Dean K, Franzoso G (2006) Mutual cross-Talk between reactive oxygen species and nuclear factor-kappa B: Molecular basis and biological significance. Oncogene 25(51):6731-6748
191. Martindale JL, Holbrook NJ (2002) Cellular response to oxidative stress: Signaling for suicide and survival. J Cell Physiol 192(1):1-15
192. Nakano H, Nakajima A, Sakon-Komazawa S, Piao JH, Xue X, Okumura K (2006) Reactive oxygen species mediate crosstalk between NF-kappaB and JNK. Cell Death Differ 13(5):730-737
193. Saelim N, John LM, Wu J et al (2004) Nontranscriptional modulation of intracellular Ca2+ signaling by ligand stimulated thyroid hormone receptor. J Cell Biol 167(5):915-924
194. Biswas G, Adebanjo OA, Freedman BD et al (1999) Retrograde Ca2+ signaling in C2C12 skeletal myocytes in response to mitochondrial genetic and metabolic stress: A novel mode of inter-organelle crosstalk. Embo J 18(3):522-533
195. Luo Y, Bond JD, Ingram VM (1997) Compromised mitochondrial function leads to increased cytosolic calcium and to activation of MAP kinases. Proc Natl Acad Sci U S A 94(18):9705-9710
196. Wrutniak-Cabello C, Casas F, Cabello G (2001) Thyroid hormone action in mitochondria. J Mol Endocrinol 26(1):67-77